Russian made covid-19
vaccine "Sputnik-V" to be used for emergency use in India
* Expert panel on drugs and vaccine regulation and adminstration
in India has cleared "Sputnik
V", Russia's largely used vaccine for circulation within India
* The administration has given in to this proposition amidst
high concerns over the need to step up Covid-19 vaccine and dosages manufacture
and supply within India as there is a wide bridge in demand and supply within
India and thus the need for procuring the vaccine for restricted emergency use
within India .
* The final approval upon this is to be taken by the Drug
Controller of India very soon as per reports over some of the major daily
newspapers circulated in India
* Once this proposal would be approved , Hyderabad based drug
manufacturer company "Dr Reddy's Lab" will initially procure the
importing license post which it will import from Russian manufacturing company
and then it will supply to GOI
( Government of India )
* The GOI will procure "Sputnik V" from Dr Reddy's Lab
for the national Covid vaccination programme but this will be in small
quantities in the initial period.
* Stocks of the same are expected to rise by June-July 2021 as
per published reports in the newspapers
* The Central govt expects that "Sputnik V" could be
seen as a major welcome addition to "Covishield"
and "Covaxin" which
are India's inhouse conceptualised, developed , manufactured and
served vaccine for the citizens as well as for export to interested countries .
This is expected to improve the lurking gap between the prevalent supply and
demand gap as per the current trend
* It is however expected that with increased production of Covaxin , India's dependency over other countries for vaccine will fall and India might be able to cater to its citizens needs and welfare as per the dictats of AtmaNirbhar Bharat
